Medicine
Olanzapine Intramuscular 10 mg/2 mL powder for injection
Olanzapine Intramuscular 10 mg/2 mL powder for injection is a prescription medicine containing Olanzapine for intramuscular use, marketed by UBI Pharma, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
The USP defines controlled room temperature as a temperature maintained…
Key facts
- Active ingredient (INN)
- Olanzapine
- Brand
- Olanzapine Intramuscular
- Strength
- 10 mg/2 mL
- Dosage form
- Powder for injection
- Route
- Intramuscular
- Packs
- 1 vial
- Marketing authorisation holder
- UBI Pharma
- Manufacturers
- UBI PharmaPAI Pharma
- Origin register
- US FDA, United States
- Storage
- The USP defines controlled room temperature as a temperature maintained thermostatically that encompasses the usual and customary working environment of 20° to 25°C (68° to 77°F), that results in a mean kinetic temperature calculated to be not more than 25°C, and that allows for excursions between 15° and 30°C (59° and 86°F) that are experienced in pharmacies, hospitals, and warehouses.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N05AH03 Olanzapine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 8 May 2020
- Identifiers
- RxCUI 485968DailyMed set ID 9d9f25d5-4513-434a-a37a-392a0c978f2e, 6a279fe1-ed99-4a62-b2c7-831961470fa9NDC 0121-1072, 72843-576Application ANDA211072
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial in 1 carton / 2 mL in 1 vial | 72843-576-01 | UBI Pharma | 8 May 2020 |
| 1 vial in 1 carton / 2 mL in 1 vial | 0121-1072-55 | PAI Pharma | 25 July 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Olanzapine 10 mg/2 mL powder for injection.
Other strengths and forms of Olanzapine
Clinical summary
Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia, among other approved uses. It is available as tablets, orally disintegrating tablets and powder for injection for intramuscular and subcutaneous use. MedsAcross supplies Olanzapine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OlanzapineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Zyprexa prescribing information (H2-Pharma) · U.S. National Library of Medicine, DailyMed
- Zypadhera: European public assessment report (EPAR) · European Medicines Agency
- Zyprexa Velotab: European public assessment report (EPAR) · European Medicines Agency
Need Olanzapine Intramuscular 10 mg/2 mL powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.